EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preventative and therapeutic effects of a novel humanized anti-glycoprotein Ibα fragment of antigen-binding region in a murine model of thrombotic thrombocytopenic purpura

Liang Zheng, Reheman Adili, Zhijian Wu, Quan Zhang, Guangheng Zhu, Xi Lei, Zhenze Liu, Miguel A D Neves, Wenjing Ma, Sladjana Slavkovic, Xiaohong Ruby Xu, Heyu Ni und 1 weitere

Journal of Thrombosis and Haemostasis · 2025-05 · 23 (5) · 1596-1607

DOI: 10.1016/j.jtha.2025.02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-05. Verfasst von Liang Zheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA; Institute of Reproductive and Dev…. Hauptthemen laut MEDLINE: Purpura, Thrombotic Thrombocytopenic, Platelet Glycoprotein GPIb-IX Complex, Blood Platelets, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Blood Foundation, National Institute of Genetics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal blood disorder resulting from severe deficiency of plasma ADAMTS-13 activity. Current treatment for immune-mediated TTP includes daily therapeutic plasma exchange plus caplacizumab and immunosuppressives. For hereditary TTP resulting from mutations of ADAMTS-13, plasma infusion or recombinant ADAMTS-13 is the treatment of choice. However, there are still unmet needs for an effective alternative therapy for TTP. OBJECTIVES: The present study aimed to evaluate the therapeutic efficacy of a novel humanized antibody fragment of antigen binding against platelet glycoprotein Ibα (CA1001) in a murine model of TTP. METHODS: Platelet agglutination profiles, microfluidic shear-based assay, intravital microscopy thrombosis model, and lysine histone-induced murine "TTP-like" model were employed. RESULTS: CA1001 exhibited potent inhibition of botrocetin-induced murine platelet agglutination in a dose- and time-dependent manner. CA1001 also significantly inhibited shear-dependent adhesion and aggregation of murine platelets to endothelial von Willebrand factor (VWF) released from calcium ionophore-activated cremaster venules in Adamts-13 null mice and blocked the formation of platelet-VWF rich thrombosis. More importantly, CA1001 appeared to be efficacious in preventing and treating a histone-induced "TTP-like" syndrome in Adamts-13 null mice, demonstrated by the alleviation of thrombocytopenia, prerenal injury, and formation of microvascular thrombosis in major organ tissues. CONCLUSION: CA1001 can effectively inhibit VWF-platelet interaction and thrombus formation under various (patho)physiological conditions. Thus, CA1001 may be a potential candidate for further development as a novel therapeutic for immune-mediated and hereditary TTP and perhaps for other inflammatory thrombotic disorders such as ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombotic ThrombocytopenicPlatelet Glycoprotein GPIb-IX ComplexBlood PlateletsAntibodies, Monoclonal, HumanizedAnimalsDisease Models, Animalvon Willebrand FactorHumansADAMTS13 ProteinPlatelet AggregationMicePlatelet AdhesivenessMice, Inbred C57BLTime Factors

Stichwörter der Autor:innen

ADAMTS-13glycoprotein Ibmonoclonal antibodythrombotic thrombocytopenic purpuravon Willebrand factor

Substanzen

Platelet Glycoprotein GPIb-IX Complexvon Willebrand FactorADAMTS13 ProteinAntibodies, Monoclonal, HumanizedADAMTS13 protein, mouse

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA; Institute of Reproductive and Developmental Sciences, The University of Kansas Medical Center, Kansas C…
  • Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Bloodworks Research Institute, Seattle, Washington, USA.
  • Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA; Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South Universi…
  • Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; CCOA Therapeutics Inc, Toronto, Ontario, Canada.
  • Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; CCOA Therapeutics Inc, Toronto, Ontario, Canada; Department of La…

Förderung

  • NHLBI NIH HHS
  • National Blood Foundation
  • National Institute of Genetics
  • National Heart, Lung, and Blood Institute
  • American Heart Association Inc

Zitieren

APA

Zheng, L., Adili, R., Wu, Z., Zhang, Q., Zhu, G., Lei, X., Liu, Z., Neves, M. A. D., Ma, W., Slavkovic, S., Xu, X. R., Ni, H., & Zheng, X. L. (2025). Preventative and therapeutic effects of a novel humanized anti-glycoprotein Ibα fragment of antigen-binding region in a murine model of thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis, 23(5), 1596-1607. https://doi.org/10.1016/j.jtha.2025.02.009

Vancouver

Zheng L, Adili R, Wu Z, Zhang Q, Zhu G, Lei X, et al. Preventative and therapeutic effects of a novel humanized anti-glycoprotein Ibα fragment of antigen-binding region in a murine model of thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 2025;23(5):1596-1607. doi:10.1016/j.jtha.2025.02.009

BibTeX
@article{Zheng2025,
  author = {Zheng, Liang and Adili, Reheman and Wu, Zhijian and Zhang, Quan and Zhu, Guangheng and Lei, Xi and Liu, Zhenze and Neves, Miguel A D and Ma, Wenjing and Slavkovic, Sladjana and Xu, Xiaohong Ruby and Ni, Heyu and Zheng, X Long},
  title = {Preventative and therapeutic effects of a novel humanized anti-glycoprotein Ibα fragment of antigen-binding region in a murine model of thrombotic thrombocytopenic purpura},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  volume = {23},
  number = {5},
  pages = {1596--1607},
  doi = {10.1016/j.jtha.2025.02.009}
}
Kostenlos starten →